NCT02293447View on ClinicalTrials.gov

Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Uterine Leiomyomas
Interventions
DRUG

Lidocaine per-embolization

10mL of 1% lidocaine will be mixed with the embolization particles. Lidocaine will therefore be injected during the embolization.

DRUG

Lidocaine post-embolization

10mL of 1% lidocaine will be injected in both uterine arteries after the embolization endpoint is achieved.

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02293447 - Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization | Biotech Hunter | Biotech Hunter